InvestorsHub Logo
Followers 9
Posts 917
Boards Moderated 0
Alias Born 05/12/2005

Re: None

Tuesday, 08/06/2019 11:02:41 AM

Tuesday, August 06, 2019 11:02:41 AM

Post# of 470066
I believe this story is already out there...but this is a different take on it. Does anyone think this type of "machine learning" is in competition with Ariana/Illumina?

Model predicts cognitive decline due to Alzheimer’s, up to two years out
Researchers hope the system can zero in on the right patients to enroll in clinical trials, to speed discovery of drug treatments.
Rob Matheson | MIT News Office
August 1, 2019

Studies suggest greater success in bringing drugs to market could come down to recruiting candidates who are in the disease’s early stages, before symptoms are evident, which is when treatment is most effective. In a paper to be presented next week at the Machine Learning for Health Care conference, MIT Media Lab researchers describe a machine-learning model that can help clinicians zero in on that specific cohort of participants.



Next, the researchers are hoping to partner with pharmaceutical firms to implement the model into real-world Alzheimer’s clinical trials. Rudovic says the model can also be generalized to predict various metrics for Alzheimer’s and other diseases.



https://news.mit.edu/2019/model-predicts-alzheimers-decline-0802
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News